Jussi Hernesniemi

Medicine & Life Sciences

1. Atherosclerotic Plaques 100%
2. Cerebrovascular Disorders 99%
3. Coronary Artery Disease 99%
4. Mortality 97%
5. Lipoproteins 90%
6. Genome-Wide Association Study 83%
7. Sarcopenia 83%
8. Netrin Receptors 79%
9. symmetric dimethylarginine 78%
10. dimethylarginine 78%
11. Netrin-1 75%
12. Population 74%
13. Single Nucleotide Polymorphism 72%
14. Meta-Analysis 71%
15. Atherosclerosis 67%
16. Abdominal Aortic Aneurysm 65%
17. Purinergic P1 Receptors 59%
18. Health Surveys 57%
19. Catheter Ablation 55%
20. Apolipoprotein A-I 54%
21. ST Elevation Myocardial Infarction 53%
22. Survival 53%
23. Sudden Cardiac Death 52%
24. Carotid Intima-Media Thickness 50%
25. Bundle-Branch Block 49%
26. oxidized low density lipoprotein 48%
27. Adenosine Diphosphate 47%
28. Elasticity 47%
29. Stroke 46%
30. Hydroxymethylglutaryl-CoA Reductase Inhibitors 46%
31. Genome 46%
32. Clopidogrel 46%
33. Prasugrel Hydrochloride 45%
34. Thrombectomy 45%
35. Blood Pressure 45%
36. Ticagrelor 45%
37. Arteries 44%
38. Cardiovascular Diseases 43%
39. Atrial Fibrillation 42%
40. Heart Ventricles 42%
41. Smooth Muscle Myocytes 42%
42. Cues 41%
43. Carotid Arteries 40%
44. Longitudinal Studies 39%
45. Heart Diseases 38%
46. Odds Ratio 37%
47. Transcription Factors 35%
48. Body Mass Index 35%
49. Heart Failure 35%
50. Heart Rate 34%